2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$3.20-$0.005 (-0.16%)
Price as of Sep 11, 2026 7:58 PM EDT- $1.7BMarket Cap
- -33.75%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$3.20-$0.005 (-0.16%)
Earnings Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 2.17% | ||
12-Month Momentum | -32.16% | ||
3-Month Risk Adjusted Momentum | 9.19% | ||
12-Month Risk Adjusted Momentum | -47.33% |
True Yield
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.01% | ||
Net Debt Paydown Yield | 0.11% |
Financial Health Score
Valuation | RXRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |